Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
APYX
$2.61
+4.40%
APYX
· Apyx Medical Corp
$2.61
+0.11 (+4.40%)
At close · Oct 28
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$109.94M
Shares
42.12M
Volume · Oct 28
34.76K
Avg daily vol (3M)
141.88K
All webcasts
Earnings call · FY2026 Q2
Apyx Medical Corp (APYX) Q2 2026 Earnings Call
Revenue
$13.88M
+22.1% YoY
Gross margin
63.9%
+1.6 pp YoY
Net income
-$3.24M
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenue
Maintained
year ending December 31, 2026
|
$59M – $60M | — | |
|
Surgical Aesthetics revenue
Maintained
year ending December 31, 2026
|
$54M – $55M | — | |
|
OEM revenue
Maintained
year ending December 31, 2026
|
$5M | — | |
|
Operating expenses
year ended December 31, 2026
|
up to $45M | — |
Quarter detail
How the reported period landed and where the business moved.
Company presentation
Slides
20 pages · use arrow keys or swipe to navigate
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document